主动脉僵硬度、脉压与脑搏动性在最佳药物治疗下仍进展:OXVASC队列
在OXVASC队列中,188例短暂性脑缺血发作或非致残性卒中患者于中位5.8年后复测,发现主动脉脉搏波速度(PWV)和主动脉脉压(aoPP)显著进展,而大脑中动脉搏动指数(MCA-PI)整体无显著进展,但55岁以上人群aoPP和MCA-PI显著增加。
要点
- PWV和aoPP在最佳药物治疗后仍显著进展,PWV年进展2.4%,aoPP年进展3.5%。
- 55岁以上人群aoPP和MCA-PI显著增加,PWV随年龄增长进展更快。
- 较高的主动脉收缩压和舒张压预测PWV和aoPP进展更快,但不预测MCA-PI进展。
核心结论
- 尽管接受最佳药物治疗,55岁后动脉搏动性和主动脉僵硬度仍显著进展。
- 僵硬度与aoPP的进展由高血压决定,而MCA-PI主要反映当前aoPP。
研究设计与样本
- OXVASC队列中连续纳入短暂性脑缺血发作或非致残性卒中6周内患者,共188例完成中位5.8年复测。
- 采用平面压力波测定法测量PWV和aoPP,经颅多普勒测量MCA-PSV、MCA-EDV和MCA-PI。
主要发现
- PWV、aoPP和MCA-PI重复性高,组内相关系数分别为0.71、0.59和0.65。
- PWV进展2.4%(P<0.0001),aoPP进展3.5%(P<0.0001),MCA-PI整体无显著进展(0.93;P=0.22)。
- PWV随年龄增长进展更快(0.009 m/s每年每岁;P<0.0001),55岁以上aoPP(P<0.0001)和MCA-PI(P=0.009)显著增加。
- 较高的主动脉收缩压和舒张压预测PWV和aoPP进展更快,但不预测MCA-PI进展。
- 当前MCA-PI与同期aoPP强烈相关(P<0.001)。
临床怎么用
- 作者认为,针对脑搏动性的治疗可能需要主要针对主动脉僵硬度和脉压,才可能预防脑小血管病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increased cerebral arterial pulsatility is associated with cerebral small vessel disease, recurrent stroke, and dementia despite the best medical treatment. However, no study has identified the rates and determinants of progression of arterial stiffness and pulsatility. METHODS: In consecutive patients within 6 weeks of transient ischemic attack or nondisabling stroke (OXVASC [Oxford Vascular Study]), arterial stiffness (pulse wave velocity [PWV]) and aortic systolic, aortic diastolic, and aortic pulse pressures (aoPP) were measured by applanation tonometry (Sphygmocor), while middle cerebral artery (MCA) peak (MCA-PSV) and trough (MCA-EDV) flow velocity and Gosling pulsatility index (PI; MCA-PI) were measured by transcranial ultrasound (transcranial Doppler, DWL Doppler Box). Repeat assessments were performed at the 5-year follow-up visit after intensive medical treatment and agreement determined by intraclass correlation coefficients. Rates of progression and their determinants, stratified by age and sex, were determined by mixed-effects linear models, adjusted for age, sex, and cardiovascular risk factors. RESULTS: In 188 surviving, eligible patients with repeat assessments after a median of 5.8 years. PWV, aoPP, and MCA-PI were highly reproducible (intraclass correlation coefficients, 0.71, 0.59, and 0.65, respectively), with progression of PWV (2.4%; P<0.0001) and aoPP (3.5%; P<0.0001) but not significantly for MCA-PI overall (0.93; P=0.22). However, PWV increased at a faster rate with increasing age (0.009 m/s per y/y; P<0.0001), while aoPP and MCA-PI increased significantly above the age of 55 years (aoPP, P<0.0001; MCA-PI, P=0.009). Higher aortic systolic blood pressure and diastolic blood pressure predicted a greater rate of progression of PWV and aoPP, but not MCA-PI, although current MCA-PI was particularly strongly associated with concurrent aoPP (P<0.001). CONCLUSIONS: Arterial pulsatility and aortic stiffness progressed significantly after 55 years of age despite the best medical treatment. Progression of stiffness and aoPP was determined by high blood pressure, but MCA-PI predominantly reflected current aoPP. Treatments targetting cerebral pulsatility may need to principally target aortic stiffness and pulse pressure to have the potential to prevent cerebral small vessel disease.
引用
- Webb AJS, Lawson A, Wartolowska K, et al. Aortic Stiffness, Pulse Pressure, and Cerebral Pulsatility Progress Despite Best Medical Management: The OXVASC Cohort. Stroke. 2021. PMID: 34852644. doi:10.1161/STROKEAHA.121.035560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。